Hiku announced that its subsidiary, DOJA Cannabis (a licensed cannabis producer under the ACMPR), submitted its application to produce medical cannabis oils at its second site facility.
Hiku also announced that it signed a strategic partnership agreement with Vitalis Extraction Technology, whereby Vitalis will advise on the build-out of the extraction lab, partner on certain research and development initiatives, and supply the facility with Vitalis' Q-90 supercritical CO2 extraction system - which is capable of processing up to 80 kg of cannabis flower per day.
We are bullish on these announcements and are favorable on the focus on the cannabis oil opportunity. We continue to believe that the trend towards smokeless products will become more pronounced and are favorable on this growth initiative. Hiku offers cannabis investors a differentiated opportunity that is levered to Canada’s recreational market and we are bullish.
Whttps://technical420.com/cannabis-article/5-canadian-cannabis-updates-impacted-shares